Medicare payments for branded neurologic drugs jumped 50% over a 5-year period, while claims for these medications increased by just
Neurologic Drug Prices Jump 50% in Five Years
Home ยป
Medicare Beneficiaries With High Out-of-Pocket Costs May Reduce Insulin Adherence
NEW YORK (Reuters Health) – Patients with diabetes who face high out-of-pocket costs under Medicare Part D may buy or
State Lawmakers Propose Tough New Bills to Curb Drug Prices
Fed up with a lack of federal action to lower prescription drug costs, state legislators around the country are pushing